7 adolescents with Symptomatic Acute Myocarditis After Pfizer-BioNTech COVID-19 mRNA technology based gene Vaccination; who will be held responsible? CDC? NIH? FDA? Health Canada? PHAC? SAGE?

by Paul Alexander

Researchers ‘report 7 cases of acute myocarditis or myopericarditis in healthy male adolescents who presented with chest pain all within 4 days after the second dose of Pfizer-BioNTech COVID-19 vaxx




Five patients had fever around the time of presentation. Acute COVID-19 was ruled out in all 7 cases on the basis of negative severe acute respiratory syndrome coronavirus 2 real-time reverse transcription polymerase chain reaction test results of specimens obtained by using nasopharyngeal swabs. None of the patients met criteria for multisystem inflammatory syndrome in children.

Six of the 7 patients had negative severe acute respiratory syndrome coronavirus 2 nucleocapsid antibody assay results, suggesting no previous infection. All patients had an elevated troponin. Cardiac MRI revealed late gadolinium enhancement characteristic of myocarditis.’

Example in patient 1:


Cardiac MRI of patient 1. Four chamber (A) and short axis (B) postcontrast images depicting apical and midchamber lateral wall subepicardial late gadolinium enhancement (arrows). Pattern and distribution are highly characteristic for myocarditis.